Volume | 38,939 |
|
|||||
News | - | ||||||
Day High | 3.3669 | Low High |
|||||
Day Low | 3.1171 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
MyMD Pharmaceuticals Inc | MYMD | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
3.35 | 3.1171 | 3.3669 | 3.33 | 3.25 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
333 | 38,939 | $ 3.28 | $ 127,643 | - | 2.00 - 70.50 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:38:08 | 24 | $ 3.15 | USD |
MyMD Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
6.97M | 2.09M | - | 0 | -8.22M | -3.93 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
MyMD Pharmaceuticals News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MYMD Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.85 | 3.3669 | 2.74 | 3.11 | 61,077 | 0.33 | 11.58% |
1 Month | 2.15 | 3.50 | 2.00 | 2.62 | 628,834 | 1.03 | 47.91% |
3 Months | 4.275 | 4.50 | 2.00 | 3.03 | 340,383 | -1.10 | -25.61% |
6 Months | 11.70 | 12.00 | 2.00 | 6.54 | 968,199 | -8.52 | -72.82% |
1 Year | 54.00 | 70.50 | 2.00 | 18.01 | 811,948 | -50.82 | -94.11% |
3 Years | 128.70 | 298.50 | 2.00 | 52.43 | 417,554 | -125.52 | -97.53% |
5 Years | 162.90 | 298.50 | 2.00 | 57.57 | 435,863 | -159.72 | -98.05% |
MyMD Pharmaceuticals Description
MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. |